Denosumab-Induced Osteonecrosis of the Jaw with FDG PET/CT imaging features.
Denosumab is a monoclonal antibody that inhibits receptor activator of nuclear factor-kappa B ligand (RANKL), which plays a crucial role in osteoclast formation, function, and survival. By blocking RANKL, denosumab helps prevent bone resorption, making it an effective therapeutic option for managin...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SJORANM GmbH (Ltd.)
2024-11-01
|
| Series: | Swiss Journal of Radiology and Nuclear Medicine |
| Subjects: | |
| Online Access: | https://sjoranm.com/sjoranm/article/view/47 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|